| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.21B | 8.41B | 7.25B | 6.56B | 5.57B | 5.33B |
| Gross Profit | 2.94B | 2.99B | 2.26B | 2.20B | 1.59B | 1.89B |
| EBITDA | 873.67M | 974.32M | 731.79M | 659.12M | 534.62M | 846.90M |
| Net Income | 185.18M | 241.68M | 95.73M | 52.38M | 11.90M | 256.20M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 7.75B | 7.74B | 7.26B | 6.77B | 7.00B |
| Cash, Cash Equivalents and Short-Term Investments | 195.81M | 198.53M | 196.79M | 219.46M | 263.08M | 147.75M |
| Total Debt | 0.00 | 1.51B | 1.38B | 1.21B | 1.00B | 951.23M |
| Total Liabilities | -4.66B | 3.09B | 3.27B | 2.87B | 2.38B | 2.60B |
| Stockholders Equity | 4.66B | 4.66B | 4.47B | 4.40B | 4.38B | 4.39B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 100.93M | -33.75M | -20.07M | 365.87M | 267.31M |
| Operating Cash Flow | 0.00 | 938.19M | 503.43M | 340.34M | 727.67M | 406.49M |
| Investing Cash Flow | 0.00 | -900.55M | -511.91M | -316.10M | -545.76M | 59.51M |
| Financing Cash Flow | 0.00 | -50.65M | 1.12M | -35.60M | -237.06M | -378.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ₹15.27B | 14.55 | ― | 0.95% | -4.65% | 9.95% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ₹16.64B | 17.39 | ― | 0.32% | 0.74% | -17.90% | |
60 Neutral | ₹14.17B | 49.54 | ― | 0.74% | -17.86% | -49.46% | |
60 Neutral | ₹19.36B | 22.28 | ― | 2.97% | 54.99% | -66.73% | |
58 Neutral | ₹18.01B | 20.15 | ― | 1.57% | 22.67% | 24.50% | |
54 Neutral | ₹13.57B | 88.91 | ― | 0.57% | 0.94% | -32.59% |
Igarashi Motors India Limited has announced that it will close its trading window for dealings in its securities from January 1, 2026, until 48 hours after the board meeting convened to consider the company’s unaudited financial results for the third quarter ending December 31, 2025. The company has notified all designated persons, including directors, employees, registrars and transfer agents, auditors, and their immediate relatives, that they are prohibited from trading in the company’s equity shares during this period, in line with SEBI’s Prohibition of Insider Trading Regulations and listing obligations, underscoring its compliance framework and governance practices around financial result disclosures.